Close

Akorn (AKRX) Tops Q3 EPS by 2c

Go back to Akorn (AKRX) Tops Q3 EPS by 2c

BofA/Merrill Lynch Downgrades Akorn (AKRX) to Underperform

November 7, 2016 7:13 AM EST

BofA/Merrill Lynch downgraded Akorn (NASDAQ: AKRX) from Buy to Underperform with a price target of $22.00.

For an analyst ratings summary and ratings history on Akorn click here. For more ratings news on Akorn click here.

Shares of Akorn closed at $19.68 yesterday.

... More

Jefferies Cuts Price Target on Akorn (AKRX) to $24; Reiterates Buy

November 4, 2016 9:52 AM EDT

Jefferies maintained a Buy rating on Akorn (NASDAQ: AKRX), and cut the price target to $24.00 (from $35.00), following the company's 3Q earnings report. Jefferies lowered estimates as re-inspection issues create more uncertainty. Assuming a 6 month delay expected revenues from pipeline products... More

RBC Capital Downgrades Akorn (AKRX) to Sector Perform

November 4, 2016 6:13 AM EDT

RBC Capital downgraded Akorn (NASDAQ: AKRX) from Outperform to Sector Perform with a price target of $24.00 (from $37.00) on a higher risk profile and challenged P&L visibility.

Analyst Randall Stanicky commented, "As previewed on Monday, we entered 3Q looking for better clarity around FDA... More